Phase 2 trial of an H5N2 live attenuated influenza vaccine (LAIV) in healthy adults.
Phase of Trial: Phase II
Latest Information Update: 11 Dec 2008
At a glance
- Drugs Influenza A virus vaccine H5N2 (Primary)
- Indications Influenza A virus infections
- Focus Pharmacodynamics
- 11 Dec 2008 New trial record.